ExploreOutcomeAssociation
Outcome

Association

Also known as: ASSOC Association Association (attribute) Association with bronchopulmonary dysplasia Association with high white blood cell count at diagnosis (>10,000 cells/uL) Association with necrotizing enterocolitis Association with severe intraventricular hemorrhage or periventricular leukomalacia Associations WBC
12 findings 2 papers 8 related entities View in graph →

Related entities

interventions
conditions
populations
studys

Findings (50)

None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Bronchopulmonary dysplasia was the strongest neonatal comorbidity associated with gastrostomy tube placement in ELBW infants, with nearly 3-fold increased adjusted odds after controlling for center an

Effect: decline; OR 2.94; CI: 95% CI 2.20-3.92

Size: OR 2.94 CI: 95% CI 2.20-3.92
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64
None
decline

Severe intraventricular hemorrhage (grade III-IV) or periventricular leukomalacia was significantly associated with gastrostomy tube placement in ELBW infants after adjustment for center and other neo

Effect: decline; OR 2.01; CI: 95% CI 1.54-2.64

Size: OR 2.01 CI: 95% CI 1.54-2.64

Papers (2)